Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells

Immunotherapy targeting glioblastoma initiating cells (GIC) is considered a promising strategy. However, GIC are prone to evade immune response and there is a need for potent adjuvants. IFN-β might enhance the immune response and here we define its net effect on the innate immunogenicity of GIC. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolpert, Fabian, Happold, Caroline, Reifenberger, Guido, Florea, Ana-Maria, Deenen, René, Roth, Patrick, Neidert, Marian Christoph, Lamszus, Katrin, Westphal, Manfred, Weller, Michael, Eisele, Günter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595134/
https://www.ncbi.nlm.nih.gov/pubmed/26441059
http://dx.doi.org/10.1371/journal.pone.0139603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595134/
https://www.ncbi.nlm.nih.gov/pubmed/26441059
http://dx.doi.org/10.1371/journal.pone.0139603

Ejemplares similares